Page last updated: 2024-11-13

saxitoxinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

saxitoxinol: reduced form of saxitoxin; used to study the metabolism of paralytic shellfish poisoning (PSP) in mammals [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID101712120
MeSH IDM0221936

Synonyms (10)

Synonym
saxitoxinol
75420-34-7
3p2yeh7qbv ,
dihydrosaxitoxin
alpha-saxitoxinol
1h,8h-pyrrolo(1,2-c)purine-4-methanol, 2,6-diamino-3a,4,9,10-tetrahydro-10-hydroxy-, 4-carbamate, (3as,4r,10r,10as)-
.alpha.-dihydrosaxitoxin
.alpha.-saxitoxinol
((3as,4r,10r,10as)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo(1,2-c)purin-4-yl)methyl carbamate
1h,8h-pyrrolo(1,2-c)purine-4-methanol, 2,6-diamino-3a,4,9,10-tetrahydro-10-hydroxy-, .alpha.-carbamate, (3as-(3a.alpha.,4.alpha.,10.beta.,10ar*))-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]